MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Mobile Brain / Body Imaging in early Parkinson’s Disease: the Twin Brain project

    M. Ajcevic, A. Buoite Stella, A. Miladinovic, M. Peskar, M. Kalc, T. Lombardo, M. Deodato, M. Catalan, U. Marusic, P. Manganotti (Trieste, Italy)

    Objective: We aimed to setup a novel Mobile Brain / Body Imaging (MoBI) system and to perform a feasibility study for the future investigations of…
  • 2023 International Congress

    Effects of theta burst transcranial ultrasound stimulation on motor cortex excitability in Parkinson’s disease.

    T. Grippe, Y. Shamli Oghli, G. Darmani, JF. Nankoo, N. Raies, C. Sarica, T. Arora, C. Rinchon, C. Gunraj, F. Cardoso, R. Chen (Toronto, Canada)

    Objective: Evaluate the neurophysiological and clinical effects of low-intensity transcranial ultrasound stimulation (TUS) of motor cortex (M1) in patients with Parkinson’s disease (PD). Background: TUS…
  • 2023 International Congress

    Alterations of the Right Olfactory Orbitofrontal Cortex and olfactory impairment in Parkinson’s Disease

    L. Pesantez Pacheco, M. Saquib, D. Ehrlich, M. Hallett, S. Horovitz (Bethesda, USA)

    Objective: To explore the potential role of the right olfactory orbitofrontal cortex in olfactory dysfunction (OD) in Parkinson’s Disease (PD). Background: The orbitofrontal cortex (OFC)…
  • 2023 International Congress

    Determination of metabotropic glutamate 2 receptor distribution with [3H]-LY-341,495 in hemi-parkinsonian rats with L-DOPA-induced dyskinesia

    E. Kim, J. Shaqfah, I. Frouni, P. Huot (Montreal, Canada)

    Objective: To determine the distribution and density of metabotropic glutamate 2 (mGlu2) receptors in the motor loop of the basal ganglia in 6-hydroxydopamine (6-OHDA)-lesioned rats…
  • 2023 International Congress

    Prediction of freezing of gait in Parkinson’s disease based on wearable sensors

    SY. Ouyang, J. Zhao, SD. Chen (Wuhan, China)

    Objective: The purpose of this study was to introduce an autoregressive predictive model to improve the accuracy for freezing of gait (FOG) prediction. Background: Parkinson’s…
  • 2023 International Congress

    The role of RNA-carrying exosomes in synaptic physiology and in synucleinopathies

    A. Chopra, T. Outeiro (Göttingen, Germany)

    Objective: Our goals were: (i) to characterize the molecular mechanisms associated with the transfer of miRNAs from astrocytes to neuronal synapses via exosomes in transgenic…
  • 2023 International Congress

    Feasibility and efficacy of a multidisciplinary telemedicine intervention program to reduce falls and gait impairment in Parkinson’s disease (NCT04694443).

    A. Garcia-Bustillo, FV. Valiñas Sieiro, A. Olivares, M. Jahouh, J. Gonzalez-Santos, M. Allende, JJ. Gonzalez-Bernal, A. Arnaiz-Gonzalez, J. Diez-Pastor, J. Trejo, JL. Garrido-Labrador, E. Cubo (Burgos, Spain)

    Objective: To evaluate the feasibility and effectiveness of a multidisciplinary telemedicine intervention program to reduce falls and to improve quality of life (QoL) in patients…
  • 2023 International Congress

    The crucial role of the visual system on the PISA syndrome in Parkinson’s disease

    A. Yoritaka, T. Hayashi, K. Fusegi, S. Nakayama, M. Ando, N. Hattori (Koshigaya, Saitama, Japan)

    Objective: Patients with Parkinson's disease (PD) are significantly disturbed in their daily life when accompanied by the PISA syndrome (PS) of lateral bending. Background: We…
  • 2023 International Congress

    Clinical practice feasibility of a wearable appcessory for quantitative evaluation of motor symptoms in Parkinson’s disease

    A. Arrais, D. Dias, J. Silva Cunha, J. Massano, C. Soares (Porto, Portugal)

    Objective: This clinical study aims to evaluate the feasibility of a novel wearable system to quantify and monitor Parkinson’s disease (PD) motor symptoms (MS). In…
  • 2023 International Congress

    Genetic subtypes of Parkinson’s disease in a Colorado clinic

    M. Lafreniere, G. Bosma, E. Forbes (Aurora, USA)

    Objective: The objective of this study is to investigate the natural history of genetic subtypes of Parkinson’s disease (PD) and characterize the genetic architecture of…
  • « Previous Page
  • 1
  • …
  • 265
  • 266
  • 267
  • 268
  • 269
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley